Bladder Cancer Podcasts Bladder Cancer RSS feedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Why bladder cancer cells that shed their Y chromosome become more aggressive
In this episode:00:45 Why losing the Y chromosome makes bladder cancer more aggressiveLoss of the Y chromosome in bladder cancer cells is associated with increased severity of disease, but the reasons behind this have been unclear. Now researchers show that the loss of this chromosome helps tumour cells evade the immune system. However, this mechanism also makes the cells more vulnerable to certain chemotherapy treatments, and the researchers hope their findings could help improve outcomes for patients in the future.Research article: Abdel-Hafiz et al.07:30 Research HighlightsHow pollution particles ferry influenza virus d...
Source: Nature Podcast - June 21, 2023 Category: Science Authors: Springer Nature Limited Source Type: podcasts

Emergency Care Bundle for Heart Failure, AI Detection of Cancer Genes, Bladder Cancer Review, and more
Editor's Summary by Howard Bauchner, MD, Editor in Chief of JAMA, the Journal of the American Medical Association, for the November 17, 2020 issue (Source: JAMA: This Week's Audio Commentary)
Source: JAMA: This Week's Audio Commentary - November 17, 2020 Category: General Medicine Authors: JAMA Network Source Type: podcasts

Data on Enfortumab in Post-Platinum and I-O Bladder Cancer
Bradley McGregor MD, Instructor, Medicine, Harvard Medical School, Clinical Director, Lank Center for Genitourinary Oncology, GU Network Liaison, Dana Farber Cancer Institute explains the data on enfo... Author: obr Added: 07/01/2019 (Source: Oncology Tube)
Source: Oncology Tube - July 1, 2019 Category: Cancer & Oncology Source Type: podcasts

Combo Ipilimumab + Nivolumab in Histologies of Bladder Cancer
Bradley McGregor MD, Instructor, Medicine, Harvard Medical School, Clinical Director, Lank Center for Genitourinary Oncology, GU Network Liaison, Dana Farber Cancer Institute offers his insight on the... Author: obr Added: 07/01/2019 (Source: Oncology Tube)
Source: Oncology Tube - July 1, 2019 Category: Cancer & Oncology Source Type: podcasts

The Challenges Using Biomarkers For Treatment Selection In Bladder Cancer
Yair Lotan, MD, Professor of Urology, Chief of Urologic Oncology, University of Texas Southwestern Medical Center, Discusses The Challenges Using Biomarkers For Treatment Selection In Bladder Cancer. ... Author: obr Added: 03/20/2019 (Source: Oncology Tube)
Source: Oncology Tube - March 20, 2019 Category: Cancer & Oncology Source Type: podcasts

The Role Of Checkpoint Inhibitors In Bladder Cancer
Yair Lotan, MD, Professor of Urology, Chief of Urologic Oncology, University of Texas Southwestern Medical Center, Discusses The Role Of Checkpoint Inhibitors In Bladder Cancer. At The 2019 Genitourin... Author: obr Added: 03/20/2019 (Source: Oncology Tube)
Source: Oncology Tube - March 20, 2019 Category: Cancer & Oncology Source Type: podcasts

Molecular Characterization & Subtyping Data In Bladder Cancer
Yair Lotan, MD, Professor of Urology, Chief of Urologic Oncology, University of Texas Southwestern Medical Center, Discusses Molecular Characterization & Subtyping Data In Bladder Cancer. At The 2019 ... Author: obr Added: 03/20/2019 (Source: Oncology Tube)
Source: Oncology Tube - March 20, 2019 Category: Cancer & Oncology Source Type: podcasts

The Latest In Screening For High-Risk Asymptomatic Bladder Cancer
Yair Lotan, MD, Professor of Urology, Chief of Urologic Oncology, University of Texas Southwestern Medical Center, Discusses The Latest In Screening For High-Risk Asymptomatic Bladder Cancer. At The 2... Author: obr Added: 03/20/2019 (Source: Oncology Tube)
Source: Oncology Tube - March 20, 2019 Category: Cancer & Oncology Source Type: podcasts

Outcomes Of KEYNOTE 057 In High-Risk Non-Muscle-Invasive Bladder Cancer
Yair Lotan, MD, Professor of Urology, Chief of Urologic Oncology, University of Texas Southwestern Medical Center, Discusses Outcomes Of KEYNOTE 057 In High-Risk Non-Muscle-Invasive Bladder Cancer. At... Author: obr Added: 03/20/2019 (Source: Oncology Tube)
Source: Oncology Tube - March 20, 2019 Category: Cancer & Oncology Source Type: podcasts

Arjun Balar, MD - Keeping Pace With Immunotherapy Advances in Bladder Cancer: Tools for Winning the Race and Optimizing Patient Outcomes
Keeping Pace With Immunotherapy Advances in Bladder Cancer: Tools for Winning the Race and Optimizing Patient Outcomes (Source: PeerView CME/CE Audio Podcast - Oncology)
Source: PeerView CME/CE Audio Podcast - Oncology - February 19, 2019 Category: Cancer & Oncology Authors: PVI, PeerView Institute for Medical Education Tags: Science, Medicine Source Type: podcasts

Arjun Balar, MD - Keeping Pace With Immunotherapy Advances in Bladder Cancer: Tools for Winning the Race and Optimizing Patient Outcomes
Keeping Pace With Immunotherapy Advances in Bladder Cancer: Tools for Winning the Race and Optimizing Patient Outcomes (Source: PeerView CME/CE Audio Podcast - Immunology)
Source: PeerView CME/CE Audio Podcast - Immunology - February 19, 2019 Category: Allergy & Immunology Authors: PVI, PeerView Institute for Medical Education Tags: Science, Medicine Source Type: podcasts

FDA Drug Safety Podcast: Updated FDA review concludes that use of pioglitazone may be linked to an increased risk of bladder cancer
(Source: FDA Drug Safety Podcasts)
Source: FDA Drug Safety Podcasts - February 9, 2019 Category: Drugs & Pharmacology Authors: U.S. Food and Drug Administration, Center for Drug Evaluation and Research Source Type: podcasts

PEDIGREE Trial & The Role It Plays In Kidney Cancer
Tian Zhang, M.D. Medical Oncologist at Duke University specializing in caring for patients with genitourinary cancers, including kidney, bladder, prostate, and testicular cancers, Discusses PEDIGREE T... Author: kidneycancer Added: 01/17/2019 (Source: Oncology Tube)
Source: Oncology Tube - January 17, 2019 Category: Cancer & Oncology Source Type: podcasts

PEDIGREE Trial Coming Early 2019
Tian Zhang, M.D. Medical Oncologist at Duke University specializing in caring for patients with genitourinary cancers, including kidney, bladder, prostate, and testicular cancers, Discusses PEDIGREE T... Author: kidneycancer Added: 01/17/2019 (Source: Oncology Tube)
Source: Oncology Tube - January 17, 2019 Category: Cancer & Oncology Source Type: podcasts

Discussing JAVELIN Renal 101 & KEYNOTE-426 Data
Tian Zhang, M.D. Medical Oncologist at Duke University specializing in caring for patients with genitourinary cancers, including kidney, bladder, prostate, and testicular cancers, Discusses Discussing... Author: kidneycancer Added: 01/17/2019 (Source: Oncology Tube)
Source: Oncology Tube - January 17, 2019 Category: Cancer & Oncology Source Type: podcasts